EditorialKommentar
Response to Cestari et al
American Journal of Health-System Pharmacy · 24.06.2026 · 83 (13) · e460-e460
DOI: 10.1093/ajhp/zxag079 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 07.04.2026. Verfasst von Jennifer E Stark und 2 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Health Care System of the Ozarks Fayetteville, AR, USA. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
adverse drug reactionallodyniaglucagon-like peptide-1 receptor agonists (GLP-1RA)semaglutide
Autor:innen und Institutionen
- Veterans Health Care System of the Ozarks Fayetteville, AR, USA.
- Veterans Health Care System of the Ozarks Springfield, MO, USA.
Zitieren
APA
Stark, J. E., Klass, M., & Owen, L. (2026). Response to Cestari et al. American Journal of Health-System Pharmacy, 83(13), e460-e460. https://doi.org/10.1093/ajhp/zxag079
Vancouver
Stark JE, Klass M, Owen L. Response to Cestari et al. American Journal of Health-System Pharmacy. 2026;83(13):e460-e460. doi:10.1093/ajhp/zxag079
BibTeX
@article{Stark2026,
author = {Stark, Jennifer E and Klass, Marian and Owen, Lauren},
title = {Response to Cestari et al},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
volume = {83},
number = {13},
pages = {e460--e460},
doi = {10.1093/ajhp/zxag079}
}
EUVIMED